Finance

Beta
Lists
301408:SHE
Anhui Huaren Health Pharmaceuticl Co Ltd
CNÂ¥16.27
-0.91%
(-0.15) 1D
Jun 5, 3:04:25 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 301408...
Open
CNÂ¥16.98
High
CNÂ¥17.08
Low
CNÂ¥16.12
Mkt. cap
6.57B
Avg. vol.
24.41M
Volume
13.14M
Dividend
0.61%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
May 27, 2026
P/E ratio
31.07
52-wk high
CNÂ¥29.76
52-wk low
CNÂ¥11.50
EPS
CNÂ¥0.52
Shares outstanding
400.01M
No. of employees
9K
Open
CNÂ¥16.98
High
CNÂ¥17.08
Low
CNÂ¥16.12
Mkt. cap
6.57B
Avg. vol.
24.41M
Volume
13.14M
Dividend
0.61%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
May 27, 2026
P/E ratio
31.07
52-wk high
CNÂ¥29.76
52-wk low
CNÂ¥11.50
EPS
CNÂ¥0.52
Shares outstanding
400.01M
No. of employees
9K
News stories
From sources across the web
About Anhui Huaren Health Pharmaceuticl Co Ltd
CEO-
Employees8.94K
FoundedJun 29, 2001
Headquarters-
SectorDrug
Websitehrjkjt.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.24B
1.39B
1.59B
1.42B
Cost of goods sold
835.23M
920.83M
1.04B
921.66M
Cost of revenue
835.23M
920.83M
1.04B
921.66M
Research and development expenses
6.34M
9.69M
7.03M
9.56M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
331.32M
359.24M
396.06M
360.23M
Operating expense
343.47M
372.83M
419.52M
376.51M
Total operating expenses
1.18B
1.29B
1.46B
1.30B
Operating income
58.36M
94.90M
135.33M
122.81M
Other non operating income
-145.59K
-8.66M
6.60M
-5.04M
EBT including unusual items
63.96M
74.84M
72.04M
110.79M
EBT excluding unusual items
54.36M
88.92M
127.41M
115.92M
Income tax expense
17.36M
15.13M
29.57M
24.71M
Effective tax rate
27.14%
20.22%
41.04%
22.30%
Other operating expenses
4.18M
1.12M
8.89M
4.42M
Net income
42.52M
52.98M
34.63M
79.34M
Net profit margin
3.44%
3.82%
2.17%
5.58%
Earnings per share
-
-
-
-
Interest and investment income
5.23M
2.65M
5.74M
2.32M
Interest expense
-9.06M
-
-20.14M
-4.17M
Net interest expenses
-3.83M
2.65M
-14.40M
-1.86M
Depreciation and amortization charges
-
-
-
-
EBITDA
68.62M
104.62M
146.42M
133.90M
Gain or loss from assets sale
-1.99M
1.99M
-3.74M
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more